These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16143246

  • 1. Initial data on basiliximab in critically ill children undergoing heart transplantation.
    Ford KA, Cale CM, Rees PG, Elliott MJ, Burch M.
    J Heart Lung Transplant; 2005 Sep; 24(9):1284-8. PubMed ID: 16143246
    [Abstract] [Full Text] [Related]

  • 2. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G, Walsh G, Deshpande P, Koffman G.
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [Abstract] [Full Text] [Related]

  • 3. Basiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver transplantation: comparative study.
    Gibelli NE, Pinho-Apezzato ML, Miyatani HT, Maksoud-Filho JG, Silva MM, Ayoub AA, Santos MM, Velhote MC, Tannuri U, Maksoud JG.
    Transplant Proc; 2004 May; 36(4):956-7. PubMed ID: 15194332
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K, Isogai K, Horisawa S, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M, Takahashi K, Hirano T.
    Cell Transplant; 2012 May; 21(2-3):565-70. PubMed ID: 22793066
    [Abstract] [Full Text] [Related]

  • 5. Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation.
    Arora N, McKiernan PJ, Beath SV, deVille de Goyet J, Kelly DA.
    Pediatr Transplant; 2002 Jun; 6(3):214-8. PubMed ID: 12100505
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation.
    Mehra MR, Zucker MJ, Wagoner L, Michler R, Boehmer J, Kovarik J, Vasquez A.
    J Heart Lung Transplant; 2005 Sep; 24(9):1297-304. PubMed ID: 16143248
    [Abstract] [Full Text] [Related]

  • 7. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
    Lee BM, Oh CK, Jin SH, Kim JH, Kim SJ, Kim H, Shin GT.
    Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
    [Abstract] [Full Text] [Related]

  • 8. Two-dose basiliximab compared with two-dose daclizumab in renal transplantation: a clinical study.
    Lin M, Ming A, Zhao M.
    Clin Transplant; 2006 Sep; 20(3):325-9. PubMed ID: 16824149
    [Abstract] [Full Text] [Related]

  • 9. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status.
    Swiatecka-Urban A.
    Paediatr Drugs; 2003 Sep; 5(10):699-716. PubMed ID: 14510627
    [Abstract] [Full Text] [Related]

  • 10. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation.
    Rosenberg PB, Vriesendorp AE, Drazner MH, Dries DL, Kaiser PA, Hynan LS, Dimaio JM, Meyer D, Ring WS, Yancy CW.
    J Heart Lung Transplant; 2005 Sep; 24(9):1327-31. PubMed ID: 16143252
    [Abstract] [Full Text] [Related]

  • 11. Basiliximab: a review of its use as induction therapy in renal transplantation.
    McKeage K, McCormack PL.
    BioDrugs; 2010 Feb 01; 24(1):55-76. PubMed ID: 20055533
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of interleukin-2 receptor blockade with basiliximab in pediatric renal transplant recipients.
    Vester U, Kranz B, Testa G, Malagò M, Beelen D, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2001 Aug 01; 5(4):297-301. PubMed ID: 11472610
    [Abstract] [Full Text] [Related]

  • 13. Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction.
    Delgado DH, Miriuka SG, Cusimano RJ, Feindel C, Rao V, Ross HJ.
    J Heart Lung Transplant; 2005 Feb 01; 24(2):166-9. PubMed ID: 15701432
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Ojogho O, Sahney S, Cutler D, Baron PW, Abdelhalim FM, James S, Zuppan C, Franco E, Concepcion W.
    Pediatr Transplant; 2005 Feb 01; 9(1):80-3. PubMed ID: 15667617
    [Abstract] [Full Text] [Related]

  • 15. Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience.
    Aw MM, Taylor RM, Verma A, Parke A, Baker AJ, Hadzic D, Muiesan P, Rela M, Heaton ND, Mieli-Vergani G, Dhawan A.
    Transplantation; 2003 Mar 27; 75(6):796-9. PubMed ID: 12660504
    [Abstract] [Full Text] [Related]

  • 16. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE.
    Transplantation; 2000 Feb 27; 69(4):488-96. PubMed ID: 10708100
    [Abstract] [Full Text] [Related]

  • 17. Basiliximab and heart transplantation in Hispanics: the experience in Puerto Rico.
    Banchs HL, Carro Jiménez EJ, González V, González Cancel IF, Quintana C, Calderón R, Altieri PI, Rivera C.
    Bol Asoc Med P R; 2007 Feb 27; 99(3):191-6. PubMed ID: 19610574
    [Abstract] [Full Text] [Related]

  • 18. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
    Kahan BD, Rajagopalan PR, Hall M.
    Transplantation; 1999 Jan 27; 67(2):276-84. PubMed ID: 10075594
    [Abstract] [Full Text] [Related]

  • 19. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y, Scheele JR, Gonzalez-Pinto I, Jaurrieta EJ, Klar E, Pageaux GP, Scudamore CH, Cuervas-Mons V, Metselaar HJ, Prestele H, Girault D.
    Liver Transpl; 2002 Feb 27; 8(2):123-31. PubMed ID: 11862588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.